Opposite effects of PGI2 and PAF generated during acute myocardial ischemia in the perfused rabbit heart.
Berti
F
F
Department of Pharmacology, Chemotherapy and Medical Toxicology, University of Milan, Italy.
Magni
F
F
Rossoni
G
G
De Angelis
L
L
Galli
G
G
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism; D000818:Animals; D003327:Coronary Disease / Q000378:metabolism / Q000503:physiopathology*; D011464:Epoprostenol / Q000502:physiology*; D005343:Fibrinolytic Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000503:physiopathology*; D010972:Platelet Activating Factor / Q000031:analogs & derivatives / Q000378:metabolism / Q000502:physiology*; D011089:Polydeoxyribonucleotides / Q000494:pharmacology; D011817:Rabbits
D005343:Fibrinolytic Agents; D010972:Platelet Activating Factor; D011089:Polydeoxyribonucleotides; C037145:1-hexadecyl-2-acetyl-glycero-3-phosphocholine; C036901:defibrotide; D015121:6-Ketoprostaglandin F1 alpha; D011464:Epoprostenol